SA
RVPH

Sanctuary Advisors’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Sanctuary Advisors’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-500
Closed -$2.79K – 2613
2025
Q4 		$2.79K Hold
500
– – ﹤0.01% 2411
2025
Q3 		$3.69K Sell
500
-50
-9% -$425 ﹤0.01% 2411
2025
Q2 		$4.19K Hold
550
– – ﹤0.01% 2343
2025
Q1 		$10.5K Buy
+550
New +$17.3K ﹤0.01% 2177

Other funds holding RVPH

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Sanctuary Advisors's RVPH Position: Q1 2026 in Review

Sanctuary Advisors sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q1 2026, closing a stake of 500 shares — an estimated $2.79K sold.

Sanctuary Advisors first reported a position in RVPH in Q1 2025 and held it in 4 quarters. The position peaked at $10.5K in Q1 2025. 35 funds tracked by Wall St. Rank hold RVPH as of Q1 2026.

  • Sanctuary Advisors reported no remaining REVIVA PHARMA HLDGS INC position as of Q1 2026 after selling out during the quarter.
  • Sanctuary Advisors sold 500 REVIVA PHARMA HLDGS INC shares in Q1 2026, an estimated $2.79K.
  • Sanctuary Advisors first reported a position in REVIVA PHARMA HLDGS INC in Q1 2025 and held it in 4 quarters.
  • Sanctuary Advisors's REVIVA PHARMA HLDGS INC position peaked at $10.5K in Q1 2025.
  • 35 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q1 2026.

Based on Sanctuary Advisors's 13F filing for Q1 2026, filed 5 May 2026.